Total Live Articles: 385

Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD)

NICE CKS Premenstrual syndrome. Last revised: Sep 2024.

Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD)

Premenstrual syndrome (PMS) causes cyclical physical, psychological, and behavioural symptoms during the luteal phase of the menstrual cycle. Symptoms improve with menstruation and cause functional impairment. Premenstrual dysphoric disorder (PMDD) is a severe form of PMS with prominent mood symptoms and significant functional impairment.

This updated UKMLA guide to PMS and PMDD is based on NICE CKS, which covers definition, symptoms, diagnosis, and management.

Definition

PMS is characterised by cyclical and repetitive psychological, physical and behavioural symptoms

  • Occurring in the luteal phase of the normal menstrual cycle (time between ovulation and the onset of menstruation)
  • And is significant enough to cause functional impairment and/or affect day-to-day activities (work / school / performance / interpersonal relationships)

Premenstrual dysphoric disorder (PMDD) is a severe form of PMS.

If the woman experiences minor, transient premenstrual symptoms that do NOT cause impairment of activities of daily living or affect quality of life, these are more consistent with physiological premenstrual symptoms rather than PMS.

Risk Factors

Strongest risk factor: presence of ovulatory menstrual cycles

Other risk factors:

  • Family history
  • Mood disorders
  • Smoking
  • Alcohol consumption
  • Sexual abuse and/or trauma
  • Weight gain
  • Stress

Clinical Features

Psychological symptoms
  • Depression
  • Anxiety
  • Irritability
  • Loss of confidence
  • Mood swings
  • Poor concentration
  • Change in libido
  • Food cravings
Physical symptoms
  • Bloating
  • Breast pain and tenderness
  • Headache
  • Backache
  • Weight gain
  • Acne
  • GI disturbances
Behavioural symptoms
  • Reduced cognitive ability
  • Aggression

Investigation and Diagnosis

Primary Care

Ask the woman to conduct a prospective daily symptom diary for 2-3 cycles

  • Daily Record of Severity of Problems (DRSP) is a validated questionnaire
  • RCOG recommends against retrospective reporting of symptoms

Diagnose PMS if symptom diary shows:

  • Prominence of symptoms during the luteal phase, and
  • Resolves with the onset of menses, and
  • Followed by a symptom-free week

Symptoms should be significant enough to cause functional impairment and/or affect day-to-day activities (work / school / performance / interpersonal relationships).

Refer to secondary care if completed symptom diary alone is inconclusive.

PMDD is a severe form of PMS, diagnosis typically requires cyclical pre-menstrual symptoms (similar to PMS), but also:

  • At least 1 significant mood-related symptom (e.g. low mood, irritability, anxiety, mood lability), and
  • Causes significant impairment in daily functioning / relationships / quality of life

Secondary Care

Definitive test: GnRH agonist ovarian suppression test for 3 months

  • Resolution of symptoms after ovarian suppression is diagnostic of PMS

Management

ALL Patients (Less Severe PMS)

Category Management
Lifestyle advice
  • Regular, frequent (2–3 hourly), small, balanced meals rich in complex carbohydrates
  • Regular exercise and sleep
  • Stress reduction
  • Smoking and alcohol cessation (if applicable)
Pain management (headache / cramps / generalised aches and pains)
  • NSAIDs as required (e.g. ibuprofen, naproxen, mefenamic acid)
Breast pain management
  • Wearing a well-fitted bra during the day, more supportive bra during exercise, and a soft support bra at night
  • Pharmacological
    • Paracetamol and/or ibuprofen, or
    • Topical NSAID

Advise that there is limited evidence to support the use of complementary treatments and dietary supplements (including reflexology, St John’s wort, calcium and vitamin D, ginkgo biloba, evening primrose oil, vitamin B6, and magnesium)

More Severe PMS

Consider the following if symptoms are more severe or the above management options are ineffective:

Management / medication Description / indications
COCP (e.g. drospirenone and ethinylestradiol) Especially if the woman requires contraception
Refer for CBT If the woman would benefit from psychological intervention (e.g. psychological symptoms predominate)
SSRI Consider if:

  • There are mood (affective) symptoms, or
  • Diagnosed with PMDD

If there are no underlying conditions and primary care management has failed, consider referral to a clinic with a specific interest in PMS or general gynaecology.

Secondary care management options include:

  • Transdermal oestrogen
  • Other antidepressants
  • Diuretics
  • Danazol
  • Gonadotrophin-releasing hormone (GnRH) agonists
  • Surgery (bilateral salpingo-oophorectomy with or without hysterectomy)

References

Related Articles

Contraception (Non-Emergency)

Depression

Antidepressants

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Be first to accessour QBank

Sign up to receive major guideline updates and early access when we launch.